New RTP startup backed by Eshelman aims at cancer treatment
With financial backing by one North Carolina's most influential venture capitalists, a new Research Triangle Firm is taking technology out of G1 Therapeutics to develop its own can…
With financial backing by one North Carolina's most influential venture capitalists, a new Research Triangle Firm is taking technology out of G1 Therapeutics to develop its own can…